174 related articles for article (PubMed ID: 15212582)
1. Biomarkers: diagnostic highlights and surrogate end points. Cambridge Healthtech Institute's biomarker series: biomarker validation: bringing discovery to the clinic & cancer biomarkers: from discovery to clinical practice. May 3-5, 2004, Philadelphia, Pennsylvania, USA.
Levenson VV
Pharmacogenomics; 2004 Jul; 5(5):459-61. PubMed ID: 15212582
[No Abstract] [Full Text] [Related]
2. The Future of Cancer Diagnostics: Next Generation Molecular Technologies - Cambridge Healthtech Institute's Inaugural Conference.
Martin FL
IDrugs; 2008 Nov; 11(11):787-90. PubMed ID: 18988119
[TBL] [Abstract][Full Text] [Related]
3. Cambridge Healthtech Institute's 7th Annual, identifying and validating metabolic markers for drug development and clinical studies.
Beger RD
Expert Rev Mol Diagn; 2007 Mar; 7(2):113-5. PubMed ID: 17331060
[No Abstract] [Full Text] [Related]
4. Cambridge Healthtech Institute's 2007 Biomarker Discovery Summit.
Luke BT
Expert Rev Mol Diagn; 2007 Nov; 7(6):755-7. PubMed ID: 18020904
[No Abstract] [Full Text] [Related]
5. Early detection of cancer. Abstracts and proceedings of the National Cancer Institute's Early Detection Research Network Workshop and the Associate Program, June 13, 2004, Bethesda, Maryland, USA.
Cancer Biomark; 2005; 1(2-3):109-205. PubMed ID: 17192036
[No Abstract] [Full Text] [Related]
6. ProteinChips: the essential tools for proteomic biomarker discovery and future clinical diagnostics.
Clarke W; Chan DW
Clin Chem Lab Med; 2005; 43(12):1279-80. PubMed ID: 16309362
[No Abstract] [Full Text] [Related]
7. Towards Clinical Application of Methylated DNA Sequences as Cancer Biomarkers: A Joint NCI's EDRN and NIST Workshop on Standards, Methods, Assays, Reagents and Tools.
Kagan J; Srivastava S; Barker PE; Belinsky SA; Cairns P
Cancer Res; 2007 May; 67(10):4545-9. PubMed ID: 17510378
[TBL] [Abstract][Full Text] [Related]
8. Emerging trends in biomarker discovery: Ease of prognosis and prediction in cancer.
Sharma AK
Semin Cancer Biol; 2018 Oct; 52(Pt 1):iii-iv. PubMed ID: 29857038
[No Abstract] [Full Text] [Related]
9. The early detection research network: 10-year outlook.
Srivastava S
Clin Chem; 2013 Jan; 59(1):60-7. PubMed ID: 23160065
[TBL] [Abstract][Full Text] [Related]
10. Enzymes and related proteins as cancer biomarkers: a proteomic approach.
Liang SL; Chan DW
Clin Chim Acta; 2007 May; 381(1):93-7. PubMed ID: 17382922
[TBL] [Abstract][Full Text] [Related]
11. Surrogate End Points and Their Validation in Oncology Clinical Trials.
Zhao F
J Clin Oncol; 2016 May; 34(13):1436-7. PubMed ID: 26951314
[No Abstract] [Full Text] [Related]
12. Cancer biomarker testing in the everyday practice of pathology.
Cagle PT; Stein K; Oommen J; Shemon M; Kyle W
Arch Pathol Lab Med; 2015 May; 139(5):583-4. PubMed ID: 25927145
[No Abstract] [Full Text] [Related]
13. Cambridge Healthtech Institute's 4th Annual Recombinant Antibodies Conference.
Casey JL; Coley AM
Expert Opin Biol Ther; 2003 Aug; 3(5):859-62. PubMed ID: 12880385
[TBL] [Abstract][Full Text] [Related]
14. Cancer Biomarkers Discovery and Validation: State of the Art, Problems and Future Perspectives.
Mordente A; Meucci E; Martorana GE; Silvestrini A
Adv Exp Med Biol; 2015; 867():9-26. PubMed ID: 26530357
[TBL] [Abstract][Full Text] [Related]
15. Validation of new cancer biomarkers: a position statement from the European group on tumor markers.
Duffy MJ; Sturgeon CM; Sölétormos G; Barak V; Molina R; Hayes DF; Diamandis EP; Bossuyt PM
Clin Chem; 2015 Jun; 61(6):809-20. PubMed ID: 25882892
[TBL] [Abstract][Full Text] [Related]
16. Biomarker analysis for oncology.
Ma Y; Gamagedara S
Biomark Med; 2015; 9(9):845-50. PubMed ID: 26330199
[TBL] [Abstract][Full Text] [Related]
17. The Cambridge Healthtech Institute's 9th Annual Conference on Blood Safety.
Farrugia A
Expert Opin Drug Saf; 2003 Jul; 2(4):431-5. PubMed ID: 12904099
[TBL] [Abstract][Full Text] [Related]
18. Proteomic Approaches for Biomarker Panels in Cancer.
Tanase C; Albulescu R; Neagu M
J Immunoassay Immunochem; 2016; 37(1):1-15. PubMed ID: 26565430
[TBL] [Abstract][Full Text] [Related]
19. The Early Detection Research Network's Specimen reference sets: paving the way for rapid evaluation of potential biomarkers.
Feng Z; Kagan J; Pepe M; Thornquist M; Ann Rinaudo J; Dahlgren J; Krueger K; Zheng Y; Patriotis C; Huang Y; Sorbara L; Thompson I; Srivastava S
Clin Chem; 2013 Jan; 59(1):68-74. PubMed ID: 23193062
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic epigenetic biomarkers in cancer.
Costa-Pinheiro P; Montezuma D; Henrique R; Jerónimo C
Epigenomics; 2015; 7(6):1003-15. PubMed ID: 26479312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
